Krishna Institute of Medical Sciences Ltd
NSE: KIMS BSE: 543308
₹740.55
+10.05 (1.38%)
Sat, 07 Nov 2026, 08:42 pm
Market Cap (in Cr)30681.47
PE Ratio146.45
Dividend0
Health Services
Hospital/Nursing Management
24.5KKrishna Institute of Medical Sciences Income Statement
| Particulars | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 2.94B | 3.51B | 4.20B | 5.12B | 5.67B | 6.64B | 9.18B | 11.23B | 13.30B | 16.51B | 21.98B | 24.98B | 30.35B |
| Gross profit | 501.18M | 576.23M | 631.25M | 1.02B | 1.08B | 1.65B | 2.38B | 2.95B | 4.19B | 5.84B | 6.99B | 7.37B | 9.10B |
| Operating expenses (excl. COGS) | -102.06M | -163.28M | -161.35M | -248.51M | -243.44M | -639.01M | -1.21B | -1.08B | -1.06B | -1.28B | -2.10B | -2.27B | -2.80B |
| Selling/general/admin expenses, total | -81.72M | -123.83M | -126.56M | -206.85M | -202.07M | -566.27M | -1.15B | -1.01B | -1.02B | -1.24B | -1.95B | -2.16B | -2.65B |
| Research & development | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling/general/admin expenses, other | -81.72M | -123.83M | -126.56M | -206.85M | -202.07M | -566.27M | -1.15B | -1.01B | -1.02B | -1.24B | -1.95B | -2.16B | -2.65B |
| Other operating expenses, total | -20.34M | -39.45M | -34.79M | -41.66M | -41.37M | -72.74M | -62.55M | -67.16M | -40.86M | -45.60M | -150.47M | -108.00M | -155.00M |
| Operating income | 399.12M | 412.95M | 469.90M | 767.83M | 840.24M | 1.01B | 1.17B | 1.87B | 3.13B | 4.56B | 4.89B | 5.11B | 6.30B |
| Non-operating income, total | -121.68M | -266.10M | -328.62M | -358.81M | -312.40M | -1.23B | -1.32B | -463.54M | -343.81M | -85.28M | -38.45M | -507.00M | -720.00M |
| Interest expense, net of interest capitalized | -150.71M | -312.03M | -350.51M | -370.41M | -325.00M | -881.45M | -493.96M | -444.06M | -373.18M | -218.74M | -372.79M | -545.00M | -1.00B |
| Interest capitalized | 36.23M | 32.57M | 17.78M | 210.00K | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 28.68M | 39.02M | 21.89M | 11.60M | 12.60M | 356.17M | 45.25M | -19.48M | 21.85M | 91.05M | 77.61M | 26.00M | 206.00M |
| Non-operating interest income | 7.95M | 20.79M | 15.23M | 14.33M | 6.62M | 2.10M | 4.84M | 6.86M | 38.06M | 112.89M | 61.09M | 11.00M | 70.00M |
| Miscellaneous non-operating expense | 20.73M | 18.23M | 6.66M | -2.73M | 5.98M | 354.07M | 40.41M | -26.34M | -16.21M | -21.84M | 16.52M | 15.00M | 136.00M |
| Unusual income/expense | 350.00K | 6.91M | — | — | — | -702.87M | -871.37M | 0 | 7.52M | 42.41M | 256.73M | 12.00M | 78.00M |
| Pretax income | 277.44M | 146.85M | 141.28M | 409.02M | 527.84M | -213.44M | -153.81M | 1.41B | 2.79B | 4.47B | 4.85B | 4.60B | 5.58B |
| Taxes | -95.37M | -103.25M | -69.29M | -129.28M | -192.99M | -257.40M | -334.26M | -254.54M | -735.36M | -1.13B | -1.19B | -1.24B | -1.43B |
| Non-controlling/minority interest | — | -110.00K | -7.55M | -12.34M | -5.54M | -11.65M | 10.38M | 41.11M | -42.60M | -111.10M | -294.91M | -259.00M | -303.00M |
| After tax other income/expense | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 189.58M | 57.34M | 56.08M | 266.15M | 325.56M | -473.55M | -477.69M | 1.19B | 2.01B | 3.33B | 3.36B | 3.10B | 3.85B |
| Net income | 189.58M | 57.34M | 56.08M | 266.15M | 325.56M | -473.55M | -477.69M | 1.19B | 2.01B | 3.33B | 3.36B | 3.10B | 3.85B |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 189.58M | 57.34M | 56.08M | 266.15M | 325.56M | -473.55M | -477.69M | 1.19B | 2.01B | 3.33B | 3.36B | 3.10B | 3.85B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 608.78M | 660.40M | 792.57M | 1.12B | 1.19B | 1.42B | 1.73B | 2.57B | 3.83B | 5.29B | 6.18B | 6.57B | 8.07B |
| EBIT | 399.12M | 412.95M | 469.90M | 767.83M | 840.24M | 1.01B | 1.17B | 1.87B | 3.13B | 4.56B | 4.89B | 5.11B | 6.30B |
| Total operating expenses | -2.54B | -3.10B | -3.73B | -4.35B | -4.83B | -5.62B | -8.01B | -9.36B | -10.17B | -11.95B | -17.09B | -19.88B | -24.05B |
| Prepaid expenses | 6.36M | 12.87M | 16.70M | 9.50M | 7.84M | 11.82M | 9.43M | 10.28M | 27.30M | 21.61M | 44.65M | 77.00M | 92.00M |
| Deferred income, current | 26.73M | 24.94M | 35.29M | 41.96M | 36.06M | 45.83M | 41.30M | 27.66M | 138.22M | 135.13M | 169.69M | 242.00M | 324.00M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 481.18M | 455.19M | 455.53M | 433.40M | 886.59M | 1.36B | 6.33B | 6.33B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 240.17M | 322.09M | 390.46M | 420.73M | 455.01M | 460.14M | 515.65M | 356.73M | 358.31M | 379.38M | 492.24M | 463.00M | 468.00M |
| Deferred income, non-current | — | — | — | — | — | 420.00K | 13.48M | 12.86M | 12.37M | 0 | — | — | 0 |
| Minority interest | 30.00K | 53.26M | 58.58M | 68.48M | 73.94M | 202.15M | 262.51M | 133.05M | 124.61M | 233.31M | 2.68B | 2.65B | 2.81B |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
